Misonix   Report issue

For profit
Founded: Farmingdale NY United States (1955)
Status: Acquired by Bioventus (2021)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Other Trials (1)

Key: Misonix (0) Acquired (1)

becaplermin (regranex) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1